Traxoprodil

Traxoprodil

SCHEMBL5517640

CC(C(O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2B

The experimentally established mechanism targets of Traxoprodil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B known ✓ Q13224 6/20 1.00
GRIN1 known ✓ Q05586 4/20 1.00
CYP2D6 P10635 3/20 1.00
GRIN2D O15399 3/20 1.00
GRIN2A Q12879 3/20 1.00
GRIN2C Q14957 3/20 1.00
GRIN3B O60391 2/20 1.00
KCNH2 Q12809 2/20 1.00
GRIN3A Q8TCU5 2/20 1.00
OPRK1 P41145 2/20 0.59
OPRM1 P35372 1/20 0.59
OPRD1 P41143 1/20 0.59
OPRL1 P41146 1/20 0.59
ADRA2A P08913 4/20 0.55
HTR2A P28223 4/20 0.55
ADRA1A P35348 4/20 0.55
SIGMAR1 Q99720 3/20 0.55
HTR2B P41595 3/20 0.55
HTR1A P08908 2/20 0.55
LMNA P02545 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Traxoprodil SCHEMBL5888841 1.00 GRIN2B (1.00) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL6800343 1.00 GRIN2B (1.00) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL4248 1.00 GRIN2B (1.00) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL8337144 1.00 GRIN2B (1.00) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL6702711 1.00 GRIN2B (1.00) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL8867900 0.99 GRIN2B (0.97) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL8922418 0.99 GRIN2B (0.97) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL8867888 0.99 GRIN2B (0.97) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL27536541 0.93 GRIN2B (0.86) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A
Traxoprodil SCHEMBL7613753 0.93 GRIN2B (0.86) GRIN2BGRIN1CYP2D6GRIN2DGRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006114703-A2 METHOD OF ADMINISTRATION OF (1S,S2) -1- (4 -HYDROXYPHENYL) -2- (4-HYDR0XY-4-PHENYLPIPERIDIN-1-YL) -1- PROPANO (TRAXOPRODIL) PFIZER PRODUCTS INC. (US) 2006-11-02 WO claimed
CN-1273135-C Pharmaceutical compositions of N-methyl-D-aspartate receptor antagonists PFIZER PROD INC (US) 2006-09-06 CN claimed
CN-1211366-C Methyl sulfonate trihydrate of 1-(4-hydroxy phenyl)-2-(4-hydroxy-4-phenyl piperid-1-yl)-1-propanol and its intermidiate preparing process PFIZER PROD INC (US) 2005-07-20 CN claimed
CN-1210262-C Method for preparing mesylate salt trihydrate of 1- (4-hydroxyphenyl) -2- (4-hydroxy-4-phenylpiperidin-1-yl) -1-propanol PFIZER PROD INC (US) 2005-07-13 CN claimed
JP-2005516036-A 2005-06-02 JP claimed
CN-1615861-A (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate PFIZER (US) 2005-05-18 CN claimed
EP-1497245-A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS DSM Pharmaceuticals, Inc. (US) 2005-01-19 EP claimed
CN-1479617-A N-methyl-D-aspartate receptor agonist pharmaceutical compositions �Ʒ� 2004-03-03 CN claimed
WO-2003062180-A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL-PIPERIDIN-1-YL)-1-PROPANOL COMPOUNDS DSM N.V. (NL) 2003-07-31 WO claimed
WO-2003062181-A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS DSM PHARMACEUTICALS, INC. (US) 2003-07-31 WO claimed
EP-1254661-A1 Method for preventing dyskinesias with selective NMDA-Antagonists WARNER-LAMBERT COMPANY (US) 2002-11-06 EP claimed
CN-1322716-A Methyl sulfonate trihydrate of 1-(4-hydroxy phenyl)-2-(4-hydroxy-4-phenyl piperid-1-yl)-1-propanol and its intermidiate preparing process PFIZER PROD INC (US) 2001-11-21 CN claimed
CN-1321638-A Method for preparing mesylate salt trihydrate of 1- (4-hydroxyphenyl) -2- (4-hydroxy-4-phenylpiperidin-1-yl) -1-propanol PFIZER PROD INC (US) 2001-11-14 CN claimed
JP-2001520988-A 2001-11-06 JP claimed
EP-1024799-A1 METHOD FOR TREATING DISEASE-RELATED OR DRUG-INDUCED DYSKINESIAS WARNER-LAMBERT COMPANY (US) 2000-08-09 EP claimed
WO-1999021539-A1 METHOD FOR TREATING DISEASE-RELATED OR DRUG-INDUCED DYSKINESIAS WARNER-LAMBERT COMPANY (US) 1999-05-06 WO claimed
CN-1198739-A (1S,2S) -1- (4-hydroxyphenyl) -2- (4-hydroxy-4-phenylpiperidin-1-yl) -1-propanol mesylate trihydrate PFIZER (US) 1998-11-11 CN claimed
EP-0843661-A1 (1S,2S)-1-(4-HYDROXYPHENYL)-2-(4-HYDROXY-4-PHENYLPIPERIDIN-1-YL)-1-PROPANOLMETHANESULFONATE TRIHYDRATE PFIZER INC. (US) 1998-05-27 EP claimed
CN-1149454-A Method for curing tinnitus by nerve protecting agent PFIZER (US) 1997-05-14 CN claimed
WO-1997007098-A1 (1S,2S)-1-(4-HYDROXYPHENYL)-2-(4-HYDROXY-4-PHENYLPIPERIDIN-1-YL)-1-PROPANOLMETHANESULFONATE TRIHYDRATE PFIZER INC. (US) 1997-02-27 WO claimed